Immunic Stock (NASDAQ: IMUX) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 6.50K / 400.83K |
Day Range | - - - |
52 Wk Range | 0.95 - 2.11 |
Market Cap | $141.37M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 53 |
Short Interest | 2.62% |
Days to Cover | 7.06 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Immunic (NASDAQ:IMUX) through any online brokerage.
Other companies in Immunic’s space includes: Molecular Partners (NASDAQ:MOLN), Outlook Therapeutics (NASDAQ:OTLK), Innate Pharma (NASDAQ:IPHA), Galectin Therapeutics (NASDAQ:GALT) and Adverum Biotechnologies (NASDAQ:ADVM).
Immunic has a consensus price target of $15.44.
The stock price for Immunic (NASDAQ: IMUX) is $1.5694 last updated September 24, 2024 at 8:46 AM EDT.
There are no upcoming dividends for Immunic.
Immunic’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for Immunic.
Immunic is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.